• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型吡咯并[1,2-]哒嗪的通过介离子恶唑并哒嗪酮的合成、表征和细胞毒性评价。

Synthesis, Characterization and Cytotoxic Evaluation of New Pyrrolo[1,2-]pyridazines Obtained via Mesoionic Oxazolo-Pyridazinones.

机构信息

Department of Organic Chemistry, Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, 6 Traian Vuia Street, 020956 Bucharest, Romania.

Center of Immunology, "Stefan S. Nicolau" Institute of Virology, Romanian Academy, 285 Mihai Bravu Ave., 030304 Bucharest, Romania.

出版信息

Int J Mol Sci. 2023 Jul 19;24(14):11642. doi: 10.3390/ijms241411642.

DOI:10.3390/ijms241411642
PMID:37511401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10380841/
Abstract

New pyrrolo[1,2-]pyridazines were synthesized by 3 + 2 cycloaddition reaction between mesoionic oxazolo-pyridazinones and methyl/ethyl propiolate. The mesoionic compounds were generated in situ by action of acetic anhydride on 3(2)pyridazinone acids obtained from corresponding esters by alkaline hydrolysis followed by acidification. The structures of the compounds were confirmed by elemental analyses and IR, H-NMR, C-NMR, and X-ray diffraction data. The regioselectivity of cycloaddition was evidenced by NMR spectroscopy and confirmed by X-ray analysis. The compounds were evaluated for their cytotoxicity on plant cells ( L.) and crustacean animal cells ( Kellogg and Straus). The results indicated that the tested compounds exhibited low toxicity on the plant cell (IC values higher than 200 µM), while on Artemia nauplii no lethality was observed. Daphnia magna assay showed that pyrrolo[1,2-]pyridazines and could exhibit toxic effects, whereas, for the other compounds, toxicity was low to moderate. Also, the cytotoxic effects of the compounds were tested on three human adenocarcinoma-derived adherent cell lines (colon LoVo, ovary SK-OV-3, breast MCF-7). The in vitro compound-mediated cytotoxicity assays, performed by the MTS technique, demonstrated dose- and time-dependent cytotoxic activity for several compounds, the highest anti-tumor activity being observed for , and , especially against colon cancer cells.

摘要

新的吡咯并[1,2-]哒嗪是通过中氧杂唑并哒嗪酮和甲基/乙基丙炔酸酯之间的 3 + 2 环加成反应合成的。中氧杂化合物是通过醋酸酐作用于 3(2)哒嗪酮酸原位生成的,3(2)哒嗪酮酸是通过相应酯的碱性水解和酸化得到的。化合物的结构通过元素分析和 IR、H-NMR、C-NMR 和 X 射线衍射数据得到确认。NMR 光谱证实了环加成的区域选择性,并通过 X 射线分析得到了证实。通过植物细胞(L.)和甲壳动物细胞(Kellogg 和Straus)评估了化合物的细胞毒性。结果表明,测试的化合物对植物细胞的毒性较低(IC 值高于 200 µM),而对卤虫无致死作用。水蚤试验表明,吡咯并[1,2-]哒嗪和可以表现出毒性作用,而其他化合物的毒性则较低至中等。此外,还测试了化合物对三种人腺癌细胞系(结肠 LoVo、卵巢 SK-OV-3、乳腺 MCF-7)的细胞毒性。通过 MTS 技术进行的体外化合物介导的细胞毒性测定表明,几种化合物具有剂量和时间依赖性的细胞毒性活性,其中化合物、和表现出最高的抗肿瘤活性,尤其是对结肠癌细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/324cda3e5454/ijms-24-11642-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/2906ce822def/ijms-24-11642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/920062bec59e/ijms-24-11642-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/7de69d7323ab/ijms-24-11642-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/df39ef3052e7/ijms-24-11642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/b1abcaa9bcd0/ijms-24-11642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/3a11df0a4241/ijms-24-11642-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/58f57076c210/ijms-24-11642-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/94d8c42c4c41/ijms-24-11642-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/b3a2fcc7546a/ijms-24-11642-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/2deb12a18c0c/ijms-24-11642-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/f224cef1de64/ijms-24-11642-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/d2aeed6c4df9/ijms-24-11642-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/f9bece0838b8/ijms-24-11642-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/8c9cfe872ae1/ijms-24-11642-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/2bc2da0c090d/ijms-24-11642-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/66112299cecc/ijms-24-11642-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/a65d5433e4b7/ijms-24-11642-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/8b03ed1bbc6c/ijms-24-11642-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/411fa372151b/ijms-24-11642-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/324cda3e5454/ijms-24-11642-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/2906ce822def/ijms-24-11642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/920062bec59e/ijms-24-11642-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/7de69d7323ab/ijms-24-11642-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/df39ef3052e7/ijms-24-11642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/b1abcaa9bcd0/ijms-24-11642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/3a11df0a4241/ijms-24-11642-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/58f57076c210/ijms-24-11642-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/94d8c42c4c41/ijms-24-11642-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/b3a2fcc7546a/ijms-24-11642-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/2deb12a18c0c/ijms-24-11642-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/f224cef1de64/ijms-24-11642-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/d2aeed6c4df9/ijms-24-11642-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/f9bece0838b8/ijms-24-11642-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/8c9cfe872ae1/ijms-24-11642-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/2bc2da0c090d/ijms-24-11642-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/66112299cecc/ijms-24-11642-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/a65d5433e4b7/ijms-24-11642-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/8b03ed1bbc6c/ijms-24-11642-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/411fa372151b/ijms-24-11642-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/10380841/324cda3e5454/ijms-24-11642-g017.jpg

相似文献

1
Synthesis, Characterization and Cytotoxic Evaluation of New Pyrrolo[1,2-]pyridazines Obtained via Mesoionic Oxazolo-Pyridazinones.新型吡咯并[1,2-]哒嗪的通过介离子恶唑并哒嗪酮的合成、表征和细胞毒性评价。
Int J Mol Sci. 2023 Jul 19;24(14):11642. doi: 10.3390/ijms241411642.
2
New Pyrrole Derivatives as Promising Biological Agents: Design, Synthesis, Characterization, In Silico, and Cytotoxicity Evaluation.新型吡咯衍生物作为有前途的生物制剂:设计、合成、表征、计算机辅助和细胞毒性评估。
Int J Mol Sci. 2022 Aug 9;23(16):8854. doi: 10.3390/ijms23168854.
3
Discovery of novel pyrrolo-pyridine/pyrimidine derivatives bearing pyridazinone moiety as c-Met kinase inhibitors.发现带有哒嗪酮部分的新型吡咯并吡啶/嘧啶衍生物作为c-Met激酶抑制剂
Eur J Med Chem. 2017 Dec 1;141:538-551. doi: 10.1016/j.ejmech.2017.10.027. Epub 2017 Oct 13.
4
Synthesis and bioevaluation of 6-chloropyridazin-3-yl hydrazones and 6-chloro-3-substituted-[1,2,4]triazolo[4,3-b]pyridazines as cytotoxic agents.6-氯哒嗪-3-基腙和 6-氯-3-取代-[1,2,4]三唑并[4,3-b]哒嗪类化合物的合成及生物评价作为细胞毒性剂。
Bioorg Chem. 2019 May;86:288-295. doi: 10.1016/j.bioorg.2019.01.049. Epub 2019 Feb 2.
5
Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives.新型吡咯并[1,2-b]哒嗪和吡咯并[2,1-a]酞嗪衍生物的合成、分子建模和抗癌评价。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):230-243. doi: 10.1080/14756366.2018.1550085.
6
Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights.发现 3,6-二取代哒嗪类化合物作为新型靶向细胞周期蛋白依赖性激酶 2 的抗癌剂:合成、生物学评价和计算模拟研究。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1616-1630. doi: 10.1080/14756366.2020.1806259.
7
Synthesis and biological evaluation of new 3(2)-pyridazinone derivatives as non-toxic anti-proliferative compounds against human colon carcinoma HCT116 cells.新型 3(2)-哒嗪酮衍生物的合成及生物评价作为抗人结肠癌细胞 HCT116 增殖的无毒化合物。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1100-1109. doi: 10.1080/14756366.2020.1755670.
8
Synthesis and Toxicity Evaluation of New Pyrroles Obtained by the Reaction of Activated Alkynes with 1-Methyl-3-(cyanomethyl)benzimidazolium Bromide.新型吡咯的合成及其毒性评价,该吡咯由活性炔与 1-甲基-3-(氰甲基)苯并咪唑溴反应得到。
Molecules. 2021 Oct 25;26(21):6435. doi: 10.3390/molecules26216435.
9
New derivatives of pyrrolo[3,4-d]pyridazinone and their anticancer effects.吡咯并[3,4-d]哒嗪酮的新型衍生物及其抗癌作用。
Farmaco. 2004 Jun;59(6):457-62. doi: 10.1016/j.farmac.2004.03.002.
10
Regio- and stereoselective synthesis of dispirooxindole-pyrrolocarbazole hybrids via 1,3-dipolar cycloaddition reactions: Cytotoxic activity and SAR studies.通过 1,3-偶极环加成反应区域和立体选择性合成双螺环吲哚-吡咯并咔唑杂合体:细胞毒性活性和 SAR 研究。
Eur J Med Chem. 2018 Jan 1;143:292-305. doi: 10.1016/j.ejmech.2017.11.039. Epub 2017 Nov 20.

引用本文的文献

1
Antioxidant and Cytotoxic Properties of (L.) Stem Bark Dry Extract.(L.)茎皮干提取物的抗氧化和细胞毒性特性。
Molecules. 2024 Apr 29;29(9):2053. doi: 10.3390/molecules29092053.

本文引用的文献

1
Synthesis, Spectroscopic Characterization, Antibacterial Activity, and Computational Studies of Novel Pyridazinone Derivatives.新型哒嗪酮衍生物的合成、光谱特性、抗菌活性及计算研究。
Molecules. 2023 Jan 9;28(2):678. doi: 10.3390/molecules28020678.
2
New Pyrrole Derivatives as Promising Biological Agents: Design, Synthesis, Characterization, In Silico, and Cytotoxicity Evaluation.新型吡咯衍生物作为有前途的生物制剂:设计、合成、表征、计算机辅助和细胞毒性评估。
Int J Mol Sci. 2022 Aug 9;23(16):8854. doi: 10.3390/ijms23168854.
3
Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.
新型哒嗪酮衍生物类作为选择性 MAO-B 抑制剂的开发。
Molecules. 2022 Jun 13;27(12):3801. doi: 10.3390/molecules27123801.
4
Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity.具有抗炎活性的哒嗪酮和结构相关衍生物。
Molecules. 2022 Jun 10;27(12):3749. doi: 10.3390/molecules27123749.
5
Therapeutic potential of pyrrole and pyrrolidine analogs: an update.吡咯和吡咯烷类似物的治疗潜力:最新研究进展。
Mol Divers. 2022 Oct;26(5):2915-2937. doi: 10.1007/s11030-022-10387-8. Epub 2022 Jan 25.
6
Alternative animal models in predictive toxicology.预测毒理学中的替代动物模型。
Toxicology. 2022 Jan 15;465:153053. doi: 10.1016/j.tox.2021.153053. Epub 2021 Nov 24.
7
Synthesis and Toxicity Evaluation of New Pyrroles Obtained by the Reaction of Activated Alkynes with 1-Methyl-3-(cyanomethyl)benzimidazolium Bromide.新型吡咯的合成及其毒性评价,该吡咯由活性炔与 1-甲基-3-(氰甲基)苯并咪唑溴反应得到。
Molecules. 2021 Oct 25;26(21):6435. doi: 10.3390/molecules26216435.
8
Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors.鉴定 2-取代吡咯并[1,2-b]哒嗪衍生物为新型 PARP-1 抑制剂。
Bioorg Med Chem Lett. 2021 Jan 1;31:127710. doi: 10.1016/j.bmcl.2020.127710. Epub 2020 Nov 24.
9
Rare-Earth Metal Complexes of the Antibacterial Drug Oxolinic Acid: Synthesis, Characterization, DNA/Protein Binding and Cytotoxicity Studies.含抗菌药物氧氟沙星的稀土金属配合物的合成、表征、DNA/蛋白质结合及细胞毒性研究。
Molecules. 2020 Nov 19;25(22):5418. doi: 10.3390/molecules25225418.
10
Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules.嘧啶作为一种优势结构:含嘧啶生物活性分子的抗癌活性的最新综述。
Eur J Med Chem. 2021 Jan 1;209:112946. doi: 10.1016/j.ejmech.2020.112946. Epub 2020 Oct 23.